Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Confluence Pharmaceuticals

Confluence Pharmaceuticals?uq=w9if130k
2010 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Series A2 LATEST DEAL TYPE
$1.3M LATEST DEAL AMOUNT
1 INVESTORS
Description

Developer of therapeutic medications intended for neurological development disorders. The company's medications focuses on therapeutic drug development, enabling patients to get medications to treat core social, communication and cognitive impairments associated with Fragile X Syndrome and Autism Spectrum Disorders.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 4904 Deer Ridge Drive South
  • Carmel, IN 46033
  • United States

+1 (317) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Confluence Pharmaceuticals’s full profile, request a free trial.

Confluence Pharmaceuticals Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Later Stage VC (Series A2) 07-Nov-2017 $1.3M 00.00 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Confluence Pharmaceuticals Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Elevate Ventures Venture Capital Minority 000 0000 000000 0

Confluence Pharmaceuticals Executive Team (6)

Name Title Board
Seat
Contact
Info
Kenneth Payie Ph.D Director of Chemistry, Manufacturing & Controls
Craig Erickson Discoverer & Lead Scientific Advisor
Boyd Sturdevant Jr. Co-Founder and Chairman
Steven Johns Co-Founder, Chief Executive Officer, President & Board Member
Timothy Parshall Vice President of Corporate Affairs
You’re viewing 5 of 6 executives. Get the full list »

Confluence Pharmaceuticals Board Members (3)

Name Representing Role Since Contact
Info
Boyd Sturdevant Jr. Confluence Pharmaceuticals Co-Founder and Chairman 000 0000
Phil Lodato JD Elevate Ventures Board Member 000 0000
Steven Johns Confluence Pharmaceuticals Co-Founder, Chief Executive Officer, President & Board Member 000 0000